CA whooping cough outbreak continues; Researcher explore plaque-preventing Alzheimer's vaccine;

> California has reported over 5,200 cases already this year, reports Forbes, including the death of nine babies. The state's declining vaccination rates has contributed to the outbreak. Report

> University of Texas Southwestern Medical Center researchers is developing a vaccine that help the immune system "gobble up" a protein molecule that plays a role in forming the plaque found in the brains of Alzheimer's patients. News

> The EMA has determined that there's no link between GSK's Pandemrix vaccine for H1N1 flu and narcolepsy. Story

> Los Angeles-based ImmunoCellular is using a new closed-bag system for production of its cancer vaccine candidate. The bag-based process, resulting from collaboration with the Clinical Cell and Vaccine Production Facility at the University of Pennsylvania, is churning out ICT-107, the company's lead product candidate. Report

> ImmunoCellular Therapeutics says it's developed an new way to manufacture the dendritic cell-based vaccine for the treatment of glioblastoma multiforme (GBM), a common type of brain tumor. Article

And Finally.. FDA's Top Q4 Blockbuster Drug Decisions. Article

Suggested Articles

GSK expects Shingrix supplies to rise slightly in 2020, but the real "step change" will come in 2024 with a brand-new manufacturing facility.

Ebola has claimed thousands of lives in recent outbreaks, but now the world has a licensed vaccine option in Merck's Ervebo.

Cosette Pharmaceuticals which was formed in December with a deal for dermatology projects has gone back to G&W Labs for a liquids plant.